-
Mashup Score: 0
AUA 2022 the PEDAL trial comparing multiparametric MRI and 18F-DCFPyl prostate specific membrane antigen (PSMA)-PET/CT in the diagnosis and localization of prostate cancer.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
eau 2021 Preliminary results from the PEDAL trial, A prospective single arm paired comparison of ability to diagnose and locate prostate cancer between multiparametric MRI and 18F-PSMA-PET/CT, the accuracy of 18F-DCFPyl-PSMA-PET/CT to detect and localize prostate lesions compared to multiparametric MRI (mpMRI) in men with suspected prostate cancer
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
Update from the #PEDAL trial: a prospective single-arm paired comparison of ability to diagnose and locate #ProstateCancer between multiparametric MRI and 18F-PSMA-PET/CT. Presentation by Vy Tran, MD @StVincentsMelb. #AUA22 written coverage by @WallisCJD > https://t.co/o5wdVC0AyJ https://t.co/fHCpZRAKGM